Increasing attention is focusing on chromosomal and genome structure in cancer research due to the fact that genetic abnormality plays a principal role in cancer initiation, progression and response to chemotherapeutic agents. Thousands of chromosomal aberrations such as translocation, point mutation, insertion, deletion, amplification and etc have been discovered in different types of cancer that comprehensive discovery and the functional analysis of these changes in each human cancer is not only essential for continued advances in cancer research, but also is paramount for improved cancer diagnosis and treatment and the development of new and more effective therapies with curative intent. In this case NanoCinna introduces some new products including of Translocation Assessor, MutaFind, DeletFind and Amplifind kits
Gene expression profiling is a technique used in molecular biology to query the expression of genes simultaneously. In the context of cancer, gene expression profiling has been used to more accurately classify tumors. In addition to identifying genes that correlate to survival, the information derived from these analyses, often has an impact on predicting the patient’s clinical outcome and establishment of gene expression profiles associated with prognosis. In this filed NanoCinna introduces RT Array kits that work based on Real-time PCR technique.
NanoCinna strives to deliver the best in high-value, competitive-priced Genomics and Pharmacogenomics products
NanoCinna interests to develop of "Personalized medicine". Personalized medicine is a young but rapidly advancing field of healthcare that is informed by each person's unique clinical, genetic, genomic, and environmental information. Translational medicine, fueled by the human genome project, has led to open a new field on "Personalized medicine" as "Genomic medicine" which utilized of patient's genomics data to decision of better treatment.